Autoimmune Disease Diagnostics Market share revenue valued $15bn by 2023: Fractovia.org According to the research report “Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023�, growing at 2.5% CAGR over 2016-2023, autoimmune disease diagnostics market will get a push owing to the increasing prevalence of autoimmune diseases favorable government norms, rising health awareness, and as enhanced R&D investments globally. As per NIH (National Institutes of Health) estimates, nearly 23.5 million Americans suffer from autoimmune diseases, which is a major factor boosting the demand for autoimmune disease diagnostics services in America. Moreover, rising healthcare expenditure will also positively impact global autoimmune disease diagnostics market due to the growing demand for curtailing the global disease burden expenses. NIH estimates the direct healthcare costs due to autoimmune diseases per annum to be nearly USD 100 billion. Furthermore, technological innovations in healthcare industry such as novel biomarkers, as portable diagnostic devices, genetic testing, etc. will favorably impact global autoimmune disease diagnostics industry trends over the next few years.
North America autoimmune disease diagnostics market worth USD 5.3 billion in 2015, is projected to witness a high growth over the coming years, owing to high occurrence of autoimmune ailments. Furthermore, growing popularity of portable diagnostic devices will further boost the regional growth. U.S. is projected to be a major regional revenue contributor. Europe autoimmune disease diagnostics market size was valued at USD 4.3 billion in 2015 and was the second largest region contributing towards the global revenue. High government backing in terms of financial investments along with increasing prevalence of these ailments across Europe will drive the industry growth over the coming years UK and Germany are projected to be major regional revenue pockets for Europe. Asia Pacific autoimmune disease diagnostics market is estimated to register a growth rate of o5% over the period of 2016-2023, primarily driven by the large patient base across APAC. Japan and China are predicted to contribute significantly towards the regional share.
1|Page